Cast Your Vote Here
IEA President-Elect (2017-2020)
Vote for one (1) of (3) three
Liming Lee | Miquel Porta | Vinod Srivastava
Liming Li, MD, PhD
Statement of Candidacy
I have been a full professor at the Peking University Health Science Center working in the Department of Epidemiology & Biostatistics since 1997. I served as the President of Chinese Academy of Preventive Medicine (2000-2002), the founding Director-General of Chinese Center for Disease Control and Prevention (2002-2004), and the Executive Vice President (2005-2016) and Board Chair (2007-2016) of Chinese Academy of Medical Sciences & Peking Union Medical College. I also served as the President of Asia-Pacific Academic Consortium for Public Health (APACPH) between 2000 and 2004. I am currently the Vice President of Chinese Preventive Medicine Association, the President of Chinese Epidemiology Association, the Editor-in-Chief of Chinese Journal of Epidemiology, and a WHO consulting expert for prevention and management of noncommunicable diseases. I was honored to have been awarded the Eisenhower Fellowship in 1997 and conferred as Honorary Fellow by the Faculty of Public Health of the Royal Colleges of Physicians of the United Kingdom in 2010.
I have been involved as Principal Investigator or co-Investigator in multiple national and international research projects, in areas such as cardiovascular epidemiology, epidemiology of aging, and chronic disease prevention and control, which resulted in (co)authorship of more than 110 peer-reviewed publications in international journals. I am now co-leading the China Kadoorie Biobank (CKB) study, a large cohort of 0.5 million of adult Chinese of which the primary objectives are to assess the effects of both established and emerging risk factors for many different diseases reliably. I am also leading the Chinese National Twin Registry, which aims to establish a prospective twin registry with about 60 thousands of twin pairs.
I decided to stand for election to play a bigger role in the IEA. If elected, I will seek to:
- maximize the roles of IEA in supporting capacity-building and training activities for resource-poor countries and regions and in promoting international collaborative research opportunities, based on an understanding of strengths, weaknesses, opportunities, and threats in regard to capacities for research and disease prevention and control, evidence gaps, and available resources for different regions of the world;
- foster ongoing connections and communication among young epidemiologists that builds opportunities for future international collaborations;
- promote IEA sustainable development through increasing recruitment of members, raising funds from various sources, and gain supports from governments and nongovernmental organizations; and
- enhance the involvement of Chinese epidemiologists in the IEA activities.
Miquel Porta, MD, MPH, PhD
Statement of Candidacy
- Head, Clinical & Molecular Epidemiology of Cancer Unit, Hospital del Mar Institute of Medical Research – IMIM, Barcelona.
- Professor of Preventive Medicine and Public Health, School of Medicine, Universitat Autònoma de Barcelona.
- Adjunct Professor of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hi
I am an epidemiologist who believes the world needs a strong International Epidemiological Association (IEA).
And so do we, members of the IEA: we need an efficient, open, and influential organisation. I hope you agree, and will vote for me.
Efficient in raising and using resources to achieve our aims. An example: the IEA World Congress of Epidemiology should not lose money. On the contrary, it must and can make some money, as many such meetings do. Such funds can then be invested in grants and educational activities where they are most needed; e.g., to benefit epidemiologists eager to advance their training and professional prospects. The Early Career Epidemiologists (ECE) Group clearly deserves to grow. Our association must seek more partnerships and sources of funding; for example, from bona-fide non-profit foundations and bilateral institutions. I would like to increase the number of joint membership schemes with national and specialty societies. The IEA can also be more valuable to you as an individual member.
Open to the initiatives of members –including early- and mid-career epidemiologists. More open to national associations of epidemiology, and to other scientific and professional institutions with which we regularly interact because we share values and objectives. Members can have wider avenues to propose activities and to shape the contents of scientific and educational meetings. The technologies to enable participation exist, let’s just do it. If elected, I will value inclusiveness and transparency in IEA deliberations: within Council, Regions and membership more broadly. Stronger and equitable partnerships with local and global organisations are possible. The IEA can also be more open to responsible media, and more active in social networks; they are also health determinants.
Influential in science and society, so that our discipline plays an even larger role in preventing disease and disability, and in promoting health –as well as peace, justice, freedom, knowledge– in today’s planet. In institutions and public spaces, the IEA can make more visible the material and immaterial benefits and value of epidemiologic research and practice. We have a responsibility to dialogue with and to transfer knowledge to society. Our vision and practical skills are essential to prevent and control major public health problems and to positively influence health determinants: old and emerging epidemics and pandemics, occupational and living conditions, gender equality, unhealthy behaviours, health inequities within and between rich and poor populations, violence, or health impacts of climate change. The IEA can aid us develop our professional roles in epidemiologic practice and in scientific research; the latter includes a crucial leadership as methodological innovators and thinkers, which is positively influencing numerous health, life and social disciplines. Our first-rate International Journal of Epidemiology displays our ideas, findings, creativity and commitment, and it earns critical funds for IEA: the IJE deserves strong support from Council, Regions, and all members.
Thus, our association is making important contributions. We also hold high-quality global conferences and regional meetings, try to support early career epidemiologists, and contribute to capacity-building in low and middle-income countries through courses and mentoring. But we can do more. In some areas, the IEA can help improve the professional status of epidemiologists. It can also become more proactive in regional and international initiatives that concern health and sustainable development, including projects that tackle severe problems as undernutrition and food (in)security; child and maternal mortality; infectious diseases as HIV/AIDS, malaria and tuberculosis; pollution; or chronic diseases. We must continue to help bridge the knowledge gap between rich and poor populations. If elected, my primary goal will be to build upon the work that the IEA Council is developing to further tune the IEA into such glocal challenges.
* * *
I have been a member of the IEA since January 1986, and during such 30 years I have enjoyed and actively participated as a junior and senior epidemiologist in many of its meetings and activities. I was Chairman of the IEA European Epidemiology Federation (IEA EEF) and member of the Council from 2002 to 2005. In collaboration with individual members and national associations of epidemiologists, during my tenure the IEA EEF was strengthened in several important ways. We showed that it was feasible to innovate in how the IEA serves members, and –even more important– promotes epidemiologic research and practice, science and public health. I am the current editor of A dictionary of epidemiology (Oxford University Press, 2014), which is another example of a product –rigorous, useful, plural– made of hundreds of contributions from you and other colleagues worldwide.
The research of my group is focused on the environmental, clinical and molecular epidemiology of pancreatic and other cancers. We have also published extensively on human biomonitoring and the uses of biomarkers to assess the impact of environmental factors on human health, as well as on diagnostic and therapeutic delays in cancer. I have taught at several global institutions, including Imperial College (London), Harvard, McGill, the University of North Carolina, Kuwait University, and other universities in Norh America, Latin America and Europe. I live with enthusiasm the emergence of powerful research institutions in China, India, South Africa or Nigeria along with the long-established world leaders in other parts of Asia, Western Pacific, and the North. I fully support IEA efforts to strengthen epidemiology in Africa, Eastern Mediterranean, and other promising regions.
In closing: as many of you, in my work I regularly experience that it is fully compatible to value public health practice and research, science and policies, theory and action. I am a scholar who treasures an IEA with diverse interests and professional cultures.
If, as I hope, I deserve your vote, I will devote plenty of my time to work for a more influential, open, and efficient IEA. I will work to make it an organisation more valuable to you, and more relevant for epidemiologic research and practice throughout the planet.
I would be honoured to receive your vote. Thank you for your kind attention, and warm regards.
Vinod K. Srivastava, MD, DPH, M.Sc. (LSHTM), FAMS, FIPHA, FIAPSM, FSMS
Statement of Candidacy
I am a full-time teaching faculty at a medical school in India and an active member of the International Epidemiological Association (IEA) since 1980s, teaching students and working on a range of epidemiological issues primarily in South East Asia.
- My Contributions to IEA so far:
I have worked towards promoting IEA activities in South East Asian countries through National Professional Associations and have been instrumental in improving the IEA membership in the region through joint membership scheme and organizing the IEA-South East Asia Regional Conferences in Sri Lanka, Nepal and Thailand as well as SEA Regional Symposia in World Congress of Epidemiology held at Brazil, Edinburgh and Alaska. I am also responsible for maintaining affiliation of IEA with WHO. I have also served as IEA-Regional Councilor for South East Asia Region for 6 years (208-2014) and presently serving as the Secretary of International Epidemiological Association (2014-17).
- My Plans for the IEA:
I would consider the opportunity to serve the IEA as its President an enormous honour for me. I plan to devote most of my time and energy throughout my tenure to furthering the international perspective of the IEA. I would like to work with others to expand opportunities for encouraging epidemiologists, including early career researchers, from around the world to join the IEA particularly from the low and middle income countries. I wish to help the IEA continue to strengthen and support the international community of epidemiologists across the globe as well as enhancing and supporting IEA’s current activities – meetings, scholarships, training courses, etc – in high, middle, and low income countries. I would support the extension of regional IEA meetings to bring epidemiologists from that region together to discuss common problems and develop new research collaborations. I would also encourage the establishment of regional groups similar to European and African Epidemiological Federations in other regions of the world. I would support the provision of scholarships for those from the African Federation and from other similar groups to attend regional meetings and regional training courses, as well as attending the triennial meetings of world congress of epidemiology. I would encourage further expanding the network of epidemiologists from low and middle resource countries at reduced membership costs and encourage their participation in IEA meetings. I would also like to utilize my existing relationships with colleagues in different IEA region to expand the networks further with representatives from each.
In brief, I would devote most of my time and energy throughout my tenure on the Executive Committee to further the mission of the IEA and to help make it more efficient, inclusive and a productive professional organization.
- Background and contributions to epidemiology:
I studied medicine in India and UK and started my epidemiological research and teaching at the King George’s Medical College, India. I also had opportunity to enhance my epidemiological skills at Emory University/ CDC, Atlanta. My interests and studies primarily focus on maternal and child health and program evaluation with wide range of national and international collaboration. I also taught medical students at Ahmadu Bello University Teaching Hospital, Nigeria and served as In-charge, Epidemiology Unit. I also I worked as Principal Investigator to over 20 major epidemiological research projects with funding from WHO, UNICEF, World Bank, USAID and served as State Epidemiologist (HIV/AIDS) to the Govt. of UP, India. I am currently Member the Expert Advisory Group for Polio Eradication and Member of National Task Force on Surveillance of HIV/AIDS, Govt. of India. I also served as National President of Indian Association of Preventive & Social Medicine, National President of Indian Public Health Association and Chief Editor of Indian Journal of Public Health. My epidemiological work has been recognized with award of Fellowships of the Indian Public Health Association & Indian Association of Preventive & Social Medicine (1992), National Academy of Medical Sciences, India (2006) and Indian Society of Medical Statistics (2010).
IEA Secretary (2017-2020)
Sandra I. Sulsky, MPH, PhD, United States (unopposed)
I have worked as a consultant epidemiologist since 1991, first at Epidemiology Resources, Inc. and then at Applied Epidemiology, Inc. The latter was acquired by the health sciences and environmental engineering firm, ENVIRON International Corporation, in 2003. ENVIRON was acquired by Ramboll, an international environmental engineering company, in 2015. While the vast majority of my career has been spent working in private companies, I also have worked in a semi-governmental/semi-academic position (at the Jean Meyer U.S.D.A Human Nutrition Research Center on Aging at Tufts University) and as a field consultant to a U.S. state Health Department.
My experience as an epidemiologist has focused on applying a sound understanding of epidemiological methods and concepts to a broad array of problems. When I introduce epidemiology to students or to new clients, I call it “the science of making smart comparisons”. This approach has enabled me to be a successful consultant, and to carry out research in areas including occupational injury and disability, program evaluation, and outcomes of health care. I have a strong interest in developing and promulgating methods for critically reviewing the scientific literature, and for combining lines of evidence from epidemiology and toxicology. Since 2009, I have increasingly focused my attention on identifying and developing the scientific base needed to support tobacco product regulation.
This diversity of experiences provides a broad perspective on our profession. I have used these experiences to good advantage when advising new epidemiologists and students, and I propose to carry this forward to the International Epidemiological Association. The IEA is home to epidemiologists from many countries, who practice primarily in academic and governmental positions. With its aim of facilitating communication and promoting education in and use of epidemiology, I hope that adding my experiences as a consultant may be beneficial and facilitate broadening the perspectives of the organization.
IEA Treasurer (2017-2020)
Yosikazu Nakamura, MD, MPH, FFPH, Japan (unopposed)
Graduated from Jichi Medical School (currently, Jichi Medical University) on March 1982
Graduated from School of Public Health, the University of Texas Health Science Center at Houston (MPH course) on December 1993
Medical officer of a local government of Fukuoka Prefecture (1982-1989)
Faculty member of Jichi Medical School (University) (1989-currently)
Through research associate, assistant professor, and associate professor, since 1999 Chief and Professor of Public Health
Experience as an epidemiologist
Since 1982 when graduated from the medical school, continuing epidemiological research
Main topics: epidemiology of Kawasaki disease, epidemiology of prion diseases,
distribution of dioxins in breast milk, and so on
Since 1887 when the WCE was held in Helsinki, Finland, joining every WCE except in 1993. A member of IEA since 1983 (currently a life-time member), Councillor of Western-Pacific Region (2005-2014), Chief of the Organizing Committee of the 21st WCE in Saitama Japan (19-22 August, 2017)
Since 1991 when the Japan Epidemiological Association was established, being a member of the Association. Since 1998, an Board member. Editor-in-Chief of the Journal of Epidemiology published by the Association (2002-2007)
No. of published original articles: 499 (First author in English: 48)
Proposed contribution to the International Epidemiological Association
(1) Good financial policy
Increasing the member through attractive activities of the Association
Decreasing the expenses, in case of need
(2) Training and education for young epidemiologists
Education through Web
(3) Supporting epidemiologists in developing countries and areas
Financial supporting for joining the WCE
(4) Collaboration with the WHO
Solution for health-related problems
IEA European Region Councillor (2017-2020)
Patricia Kearney, MD, MPH, PhD, Ireland (unopposed)
I am an experienced Epidemiologist and Clinical Trialist with an international research record in Population Health and Health Services Research and its effective translation for improved health. My experience, expertise and current programme of research align closely with the aims of the International Epidemiological Association to facilitate communication amongst those engaged in research and teaching of epidemiology throughout the world, and to encourage its use in all fields of health including social, community and preventative medicine.
I have extensive experience in chronic disease epidemiology and global burden of disease. I trained in Internal Medicine and subsequently Public Health and Epidemiology in Ireland, the US and the UK. As a MPH student and Fulbright Scholar at Tulane University School of Public Health and Tropical Medicine, I led work on the age and sex-specific worldwide prevalence of hypertension which resulted in a landmark publication in the Lancet that has been very widely cited. I worked in the Clinical Trial Services Unit and Epidemiological Studies Unit (CTSU) in Oxford, UK as a Wellcome Trust Research Fellow for three years and my work included individual participant data meta-analysis of clinical trials of statin therapy. I was awarded the first Beeson Fellowship outside the US to work on The Irish Longitudinal Study on Ageing (TILDA) at Trinity College Dublin. I have an ongoing leadership role in the design and conduct of large scale epidemiological studies in Ireland including TILDA. I also lead on the analysis of national and international studies from birth cohorts to cohort studies of ageing in Ireland, UK, Europe and US and have worked as a visiting Professor at the Centre for Ageing and Health at the University of Pittsburgh.
I was recently appointed Professor of Epidemiology in University College Cork where I lead a multi-disciplinary research group, ESPRIT, Evidence to Support Prevention Implementation Translation. The research being carried out by the ESPRIT team, is based on a shared vision to prevent disease by generating evidence and translating research into policy and practice. My work includes a Health Research Board Research Leader Award on the burden of diabetes in Ireland. My research output includes valid and reliable estimates of the incidence and prevalence of diabetes and diabetes related complications in Ireland as well as cross-country comparisons. These data are currently being used to generate estimates of the cost of diabetes in Ireland. Further ongoing work includes modelling the potential impact of a sugar sweetened beverage tax on the incidence of diabetes in Ireland.
I have a leadership role in the training of future researchers and am a co-PI on the national Irish PhD programme in population health. Two of my students have participated in the IEA advanced epidemiology course. I have led two successful career development and training awards for post-doctorate researchers in population health and health services research. I am also a mentor for the AURORA programme, a women-only leadership development programme developed by the Leadership Foundation for Higher Education in the UK in response to research which indicated that the level of women in influential and senior positions in higher education is now lower than 10 years ago. In 2015 I was awarded Fellowship of the Royal College of Physicians of Ireland.
As Regional Councillor, I will actively recruit new members, organize and conduct regional meetings and identify training possibilities to promote epidemiology in my region. In 2019, the joint Society for Social Medicine Annual Scientific meeting- European Epidemiology Conference will be organised by my department in Cork and I will have a leadership role in the organisation of the conference with my colleague Professor Ivan Perry. We are also planning to submit a bid to host the World Congress of Epidemiology in Cork in 2023. I will continue to encourage participation in the IEA advanced epidemiology course and will identify additional regional training opportunities in epidemiology. I will report to the Council on the needs and aspirations of members in my region and will guide and supervise the activities of the council.